Advanced search
Publication Cover
Current Medical Research and Opinion Volume 25, 2009 - Issue 1
Submit an article Journal homepage
1,007
Views
68
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea

Richard Bergenstal International Diabetes Center at Park Nicollet, Minneapolis, MN, USA
,
Andrew Lewin National Research Institute, Los Angeles, CA, USA
,
Timothy Bailey AMCR Institute Inc., Escondido, CA, USA
,
Denise Chang Novo Nordisk Inc., Princeton, NJ, USA
,
Titus Gylvin Novo Nordisk Inc., Princeton, NJ, USA
,
Victor Roberts Endocrine Clinical Research, Winter Park, FL, USACorrespondence[email protected]
& for the NovoLog Mix-vs.-Exenatide Study Group show all
Pages 65-75 | Accepted 04 Nov 2008, Published online: 01 Dec 2008

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.